These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3110027)

  • 1. Spinal fluid procoagulant activity in leukaemic patients treated with intrathecal methotrexate.
    Pagano L; Marra R; De Stefano V; Leone G
    Haematologia (Budap); 1987; 20(1):41-7. PubMed ID: 3110027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid protein findings during prophylaxis and treatment of neuromeningosis in leukaemic patients.
    Marra R; Pagano L; Storti S; Massaro A; Teofili L; Carbone G; Leone G
    Scand J Clin Lab Invest; 1987 Dec; 47(8):765-9. PubMed ID: 3432998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor VIII complex activities in acute leukemia].
    Pniejnia-Olszyński W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surface properties of cerebrospinal fluid cells following intrathecal methotrexate treatment].
    Péter A; Kádár A
    Morphol Igazsagugyi Orv Sz; 1978 Jan; 18(1):16-22. PubMed ID: 580307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stored packed red blood cells contain a procoagulant phospholipid reducible by leukodepletion filters and washing.
    Cardo LJ; Hmel P; Wilder D
    Transfus Apher Sci; 2008 Apr; 38(2):141-7. PubMed ID: 18346937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of coagulation factors in thawed, solvent/detergent-treated plasma during storage at 4 degrees C for 6 days.
    Buchta C; Felfernig M; Höcker P; Macher M; Körmöczi GF; Quehenberger P; Heinzl H; Knöbl P
    Vox Sang; 2004 Oct; 87(3):182-6. PubMed ID: 15569070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII-related antigen in cerebrospinal fluid.
    Garcia VV; Alberca I; Borrasca AL
    Thromb Haemost; 1983 Apr; 49(2):142-3. PubMed ID: 6408751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of extended storage of whole blood before leucocyte depletion on coagulation factors in plasma.
    Kretzschmar E; Kruse F; Greiss O; Paunovic D; Kallweit T; Trobisch H
    Vox Sang; 2004 Oct; 87(3):156-64. PubMed ID: 15569067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII: C and factor VIII R: Ag in Argentine hemorrhagic fever.
    Molinas FC; Maiztegui JI
    Thromb Haemost; 1981 Aug; 46(2):525-7. PubMed ID: 6795740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stability of blood coagulation factors in deep frozen fresh plasma by storage at -20 degrees C and -40 degrees C].
    Koerner K; Stampe D
    Infusionsther Klin Ernahr; 1984 Feb; 11(1):46-50. PubMed ID: 6706385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukaemic meningo-encephalopathy: treatment with intrathecal methotrexate.
    Misra RC; Basu AK
    J Assoc Physicians India; 1973 Oct; 21(10):895-903. PubMed ID: 4802076
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole blood.
    Solheim BG; Flesland O; Brosstad F; Mollnes TE; Seghatchian J
    Transfus Apher Sci; 2003 Oct; 29(2):133-9. PubMed ID: 12941351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate.
    Piedras J; Sánchez-Montero PE; Herrera FM; Córdova MS; Sánchez-Medal L
    Arch Med Res; 1993; 24(1):23-6. PubMed ID: 8292873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.